Nivolumab
Nivolumab is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer.
Product Specifications
CAS Number
[946414-94-4]
Product Name Alternative
BMS-936558; ONO-4538; MDX-1106
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Anti-PD-1_Neutralizing_Antibody_2.html
Purity
99.63
Solubility
H2O
Smiles
[Nivolumab]
Molecular Weight
(143.62 kDa)
References & Citations
[1]Wang C, et al. In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates. Cancer Immunol Res. 2014 Sep;2 (9) :846-56.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1407869-01 0.02 mg (E-Coli)
Recombinant Bovine Peptidyl-prolyl cis-trans isomerase-like 6 (PPIL6)
Ask
View Details MBS1407869-02 0.02 mg (Yeast)
Recombinant Bovine Peptidyl-prolyl cis-trans isomerase-like 6 (PPIL6)
Ask
View Details MBS1407869-03 0.1 mg (E-Coli)
Recombinant Bovine Peptidyl-prolyl cis-trans isomerase-like 6 (PPIL6)
Ask
View Details